Siatis Perry C

CIK 00019514001 companyNORTH CHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001951400

Recent Transactions

50 trades

Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-03-02$233.51/sh−5,777→ 17,510 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-03-02$235.26/sh−2,600→ 4,619 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-03-02$234.66/sh−10,291→ 7,219 total
Tax Payment
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-02-27$232.08/sh−14,850→ 23,287 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-02-25$230.00/sh−22,381→ 38,137 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-02-25$192.86/sh+7,292→ 60,518 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-02-25$175.28/sh+7,775→ 53,226 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-02-25$149.62/sh+7,314→ 45,451 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2026-02-25$192.86/sh−7,292→ 14,583 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2026-02-25$175.28/sh−7,775→ 7,774 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2026-02-25$149.62/sh−7,314→ 0 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-02-18+5,808→ 38,137 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-02-18+5,628→ 32,329 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-02-18+5,792→ 26,701 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2026-02-18+16,290→ 20,909 total
Award
AbbVie Inc.$ABBV
Option (Right to buy)
2026-02-18+19,500→ 19,500 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-03-03$149.62/sh+7,315→ 14,852 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-03-03$175.28/sh+7,775→ 22,627 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-03-03$144.54/sh+2,918→ 7,537 total
Disposition to Issuer
AbbVie Inc.$ABBV
Option (Right to buy)
2025-03-03$175.28/sh−7,775→ 15,549 total
Disposition to Issuer
AbbVie Inc.$ABBV
Option (Right to buy)
2025-03-03$149.62/sh−7,315→ 7,314 total
Disposition to Issuer
AbbVie Inc.$ABBV
Option (Right to buy)
2025-03-03$144.54/sh−2,918→ 0 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-03-03$210.00/sh−18,008→ 4,619 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-28$205.38/sh−2,718→ 11,793 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-28$207.19/sh−363→ 4,619 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-28$206.62/sh−6,811→ 4,982 total
Tax Payment
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-28$205.02/sh−7,870→ 14,511 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-20$197.40/sh−1,784→ 26,375 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-20$198.12/sh−3,994→ 22,381 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-13+4,496→ 14,893 total
Award
AbbVie Inc.$ABBV
Option (Right to buy)
2025-02-13+21,875→ 21,875 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-13+5,630→ 28,159 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-13+5,792→ 22,529 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-13+1,844→ 16,737 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-29$177.05/sh−6,504→ 13,784 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-29$178.04/sh−3,387→ 10,397 total
Tax Payment
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-28$178.99/sh−7,885→ 20,288 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-23$144.54/sh+2,919→ 31,092 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2024-02-23$149.62/sh+7,315→ 14,629 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2024-02-23$105.92/sh+3,519→ 0 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2024-02-23$144.54/sh+2,919→ 2,919 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-23$177.51/sh−13,753→ 28,173 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-23$149.62/sh+7,315→ 41,926 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-23$105.92/sh+3,519→ 34,611 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-15+5,792→ 28,173 total
Award
AbbVie Inc.$ABBV
Option (Right to buy)
2024-02-15+23,324→ 23,324 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-15+2,138→ 20,537 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-15+8,022→ 18,399 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-15+1,844→ 22,381 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-02$144.54/sh+2,919→ 13,296 total

Companies

AbbVie Inc.
EVP, GC AND SECRETARY
$ABBV

Recent Filings

Address

1 N. WAUKEGAN ROAD

NORTH CHICAGO, IL, 60064

View on SEC.gov